Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience
May 21, 2026 | clinical trials
Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.
Patient communications agency Cuttsy+Cuttsy today announces the launch of The Experience Gap – a new digital roadmap designed to transform how clinical trial teams engage, support and retain participants at every step of the journey.
Launching at Patients as Partners on 19 May, the roadmap responds to a critical moment for the industry. With 85% of trials missing recruitment targets, ongoing gaps in participant diversity, and dropout rates frequently exceeding 20% – the need for effective, human-centred communication is more important than ever.
The Experience Gap was created to help do exactly that – bringing together evidence and experience into clear, actionable steps that site teams, sponsors and CROs can apply in real-world settings. Rather than simply staying at a theoretical level, the roadmap delivers practical, moment-by-moment guidance across the entire participant journey, so every touchpoint is optimised.
From shaping first human interactions grounded in empathy and trust, to helping people stay engaged throughout their trial experience, the roadmap focuses on the moments where engagement is won or lost. It equips teams with tools to simplify consent, personalise early engagement, and anticipate and address disengagement – helping sustain participation when it matters most.
The roadmap also extends beyond the trial itself, supporting clearer, more meaningful communication at study close – an often-overlooked moment that plays a key role in building long-term trust and encouraging future participation.
Built on Cuttsy+Cuttsy’s extensive experience and informed by insights from their previous research publications, The Participation Equation and The Site Factor, the roadmap is grounded in both behavioural science and real-world site realities, with a clear focus on turning insight into practical action.
“Our ambition was simple: to make better participant experiences achievable, not aspirational,” says Stacey Davidson, Head of Content and Strategy at Cuttsy+Cuttsy. “The Experience Gap brings structure to something that’s often left to chance – helping teams design clearer, more human interactions at every stage of the trial journey.”
By focusing on the points where engagement is most easily lost – from first contact through to study close – the roadmap supports teams to deliver more thoughtful, joined-up participant experiences. As expectations continue to rise around diversity, retention and trust, The Experience Gap provides a practical framework for building trials that work better for the people taking part in them.
Reference
A Primer on the Importance of Recruitment and Retention in Clinical Trials accessed May 2026
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Permission to pause: making treatment breaks part of the cancer care conversation
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
A seat at the table: what the EU HTA reforms really ask of patient involvement
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
Why faster trials make participant understanding more important than ever
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
It’s time to stop calling adverse events ‘manageable’
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
The value: why localisation pays off across global trials
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
The solution: Good localisation doesn’t feel translated
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Healthcare information is becoming easier to access. Trust isn’t.
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.